The role of monocytes in thrombotic diseases: a review

Z Han, Q Liu, H Li, M Zhang, L You, Y Lin… - Frontiers in …, 2023 - frontiersin.org
Cardiovascular and cerebrovascular diseases are the number one killer threatening
people's life and health, among which cardiovascular thrombotic events are the most …

[HTML][HTML] Mechanism and therapeutic targets of circulating immune cells in diabetic retinopathy

B Zhao, Y Zhao, X Sun - Pharmacological Research, 2024 - Elsevier
Diabetic retinopathy (DR) continues to be the leading cause of preventable vision loss
among working-aged adults, marked by immune dysregulation within the retinal …

Diagnostic performance of novel inflammatory biomarkers based on ratios of laboratory indicators for nonalcoholic fatty liver disease

Y Zhao, J Xia, H He, S Liang, H Zhang… - Frontiers in …, 2022 - frontiersin.org
Introduction There is few effective biomarkers for diagnosing nonalcoholic fatty liver disease
(NAFLD) in clinical practice. This study was aimed to investigate the predictive ability of …

Association between monocyte to high-density lipoprotein-cholesterol ratio and osteoporosis: An analysis of the National Health and Nutrition Examination Survey …

F Zhou, L Wu, G Shen, X Chen, C Liu… - Journal of …, 2024 - journals.sagepub.com
The monocyte to high-density lipoprotein-cholesterol (HDL-C) ratio (monocyte-to-HDL-C
ratio) was proposed as a marker of atherosclerosis. Osteoporosis and atherosclerosis share …

The association between monocyte to high-density lipoprotein cholesterol ratio and chronic kidney disease in a Chinese adult population: a cross-sectional study

L Xu, D Li, Z Song, J Liu, Y Zhou, J Yang, P Wen - Renal Failure, 2024 - Taylor & Francis
Background Monocyte to high-density lipoprotein cholesterol ratio (MHR) was confirmed as
a novel inflammatory marker and strongly associated with the risk of several diseases. This …

Predictive value of monocyte to high-density lipoprotein cholesterol ratio and tumor markers in colorectal cancer and their relationship with clinicopathological …

X Zhang, H Qin, X Tan, Y Mo, Z Li, G Huang… - World Journal of Surgical …, 2023 - Springer
Objective To evaluate the predictive value of monocyte (M) to high-density lipoprotein
cholesterol (HDL-C) ratio (MHR) and tumor markers in colorectal cancer (CRC) and their …

The ratio of monocytes to HDL-cholesterol is associated with cardiovascular risk and insulin resistance in patients with rheumatoid arthritis

A Romo-Cordero, M González-Sierra… - Life, 2023 - mdpi.com
The monocytes to high-density lipoprotein (HDL)-cholesterol ratio (MHR) indicates
inflammation based on the anti-inflammatory properties of HDL-cholesterol as well as the …

Monocyte-to-high-density lipoprotein ratio and systemic immune-inflammation index: potential parameters for the evaluation of disease activity and severity in Graves' …

B Yılmaz Tuğan, A Ergen, B Özkan - International Ophthalmology, 2024 - Springer
Purpose To assess changes in monocyte-to-high-density lipoprotein (HDL) ratio (MHR),
neutrophil-to-lymphocyte ratio (NLR), and systemic immune-inflammation index (SII) with …

Can the monocyte to HDL ratio be used as an inflammation marker in patients with fibromyalgia syndrome?

E Erden, AC Turk - Nigerian Journal of Clinical Practice, 2023 - ajol.info
Abstract Background and Aim: The monocyte‑to‑high‑density lipoprotein (HDL) ratio (MHR)
may be used as a marker of inflammation and oxidative stress. This study aimed to evaluate …

The monocyte to high-density lipoprotein cholesterol ratio is a risk factor for frequent premature ventricular complexes: a retrospective cohort study

Y Wang, D Li, X Zhu, J Li, C Yue, L Wu, Q Zhuan… - Lipids in Health and …, 2022 - Springer
Background Little is known about the link between the monocyte to high-density lipoprotein
cholesterol ratio (MHR) and frequent premature ventricular complexes (PVCs). This …